SEARCH

SEARCH BY CITATION

REFERENCES

  • Anderlini, P., Donato, M., Chan, K.W., Huh, Y.O., Gee, A.P., Lauppe, M.J., Champlin, R.E. & Korbling, M. (1999) Allogeneic blood progenitor cell collection in normal donors after mobilization with filgrastim: the M.D. Anderson Cancer Center experience. Transfusion, 39, 555560.
  • Anderlini, P., Przepiorka, D., Seong, C., Smith, T.L., Huh, Y.O., Lauppe, J., Champlin, R. & Korbling, M. (1997) Factors affecting mobilization of CD34+ cells in normal donors treated with filgrastim. Transfusion, 37, 507512.
  • Aversa, F., Reisner, Y. & Martelli, M.F. (2008) The haploidentical option for high-risk haematological malignancies. Blood Cells, Molecules, and Diseases, 40, 812.
  • Ball, L.M., Bernardo, M.E., Roelofs, H., Lankester, A., Cometa, A., Egeler, R.M., Locatelli, F. & Fibbe, W.E. (2007) Cotransplantation of ex vivo-expanded mesenchymal stem cells accelerates lymphocyte recovery and may reduce the risk of graft failure in haploidentical hematopoietic stem-cell transplantation. Blood, 110, 27642767.
  • Cassens, U., Barth, I., Baumann, C., Fischer, R.J., Kienast, J., Vormoor, J. & Sibrowski, W. (2004) Factors affecting the efficacy of peripheral blood progenitor cells collections by large-volume leukapheresis with standardized processing volumes. Transfusion, 44, 15931602.
  • Chen, X., Zhang, C., Zhang, X. et al. (2009) Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies. Biology of Blood and Marrow Transplantation, 15, 266273.
  • De La Rubia, J., Arbona, C., De Arriba, F. et al. (2002) Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors. Transfusion, 42, 49.
  • Diaz, M.A., Sevilla, J., De La Rubia, J. et al. (2003) Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation. Haematologica, 88, 919922.
  • Dong, L., Wu, T., Zhang, M.J., Gao, Z.Y. & Lu, D.P. (2007) CD3+ cell dose and disease status are important factors determining clinical outcomes in patients undergoing unmanipulated haploidentical blood and marrow transplantation after conditioning including antithymocyte globulin. Biology of Blood and Marrow Transplantation, 13, 15151524.
  • Engelhardt, M., Bertz, H., Afting, M., Waller, C.F. & Finke, J. (1999) High-versus standard dose filgrastim (rhG-CSF) for mobilization of peripheral blood progenitor cells from allogeneic donors and CD34(+) immunoselection. Journal of Clinical Oncology, 17, 21602172.
  • Falanga, A., Marchetti, M., Evangelista, V. et al. (1999) Neutrophil activation and hemostatic changes in healthy donors receiving granulocyte colony stimulating factor. Blood, 93, 25062514.
  • Fischer, J.C., Frick, M., Wassmuth, R., Alexander, P., Michael, P. & Peter, W. (2005) Superior mobilisation of haematopoietic progenitor cells with glycosylated G-CSF in male but not female unrelated stem cell donors. British Journal of Haematology, 130, 740746.
  • Huang, X.J., Chang, Y.J., Zhao, X.Y. (2007) Maintaining hyporesponsiveness and polarization potential of T cells after in vitro mixture of G-CSF mobilized peripheral blood grafts and G-CSF primed bone marrow grafts in different proportions. Transplantation Immunology, 17, 193197.
  • Huang, X.J., Han, W., Xu, L.P. et al. (2004) A novel approach to human leukocyte antigen-mismatched transplantation in patients with malignant hematological disease. Chinese Medical Journal, 117, 17781785.
  • Ikeda, K., Kozuka, T. & Harada, M. (2004) Factors for PBPC collection efficiency and collection predictors. Transfusion and Apheresis Science, 31, 245259.
  • Ings, S.J., Balsa, C., Leverett, D., Mackinnon, S., Linch, D.C. & Watts, M.J. (2006) Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used. British Journal of Haematology, 134, 517525.
  • Koh, L.P. & Chao, N.J. (2008) Nonmyeloablative allogeneic hematopoietic stem cell transplant using mismatched/haploidentical donors: a review. Blood Cells, Molecules, and Diseases, 40, 2024.
  • Kozuka, T., Ikeda, K., Teshima, T. et al. (2004) Peripheral blood circulating immature cell counts predict CD34+ cell yields in G-CSF-induced PBPC mobilization in healthy donors. Transfusion, 44, 526532.
  • Lang, P., Bader, P., Schumm, M. et al. (2004) Transplantation of a combination of CD133+ and CD34+ selected progenitor cells from alternative donors. British Journal of Haematology, 124, 7279.
  • Lu, D.P., Dong, L.J., Wu, T. et al. (2006) Conditioning including antithymocyte HLA-mismatched/haploidentical blood and marrow transplantation can achieve comparable outcomes with HLA identical sibling transplantation. Blood, 107, 30653073.
  • Lysak, D., Koza, V. & Jindra, P. (2005) Factors affecting PBSC mobilization and collection in healthy donors. Transfusion and Apheresis Science, 33, 275283.
  • Miflin, G., Charley, C., Stainer, C., Anderson, S., Hunter, A., Russell, N. & Russell, N. (1996) Stem cell mobilization in normal donors for allogeneic transplantation: analysis of safety and factors affecting efficacy. British Journal of Haematology, 95, 345348.
  • Moncada, V., Bolan, C., Yau, Y. & Leitman, S.F. (2003) Analysis of PBPC cell yields during large-volume leukapheresis of subjects with a poor mobilization response to filgrastim. Transfusion, 43, 495501.
  • Moog, R. (2004) Apheresis techniques for collection of peripheral blood progenitor cells. Transfusion and Apheresis Science, 31, 207220.
  • Nomura, S., Inami, N., Kanazawa, S., Iwasaka, T. & Fukuhara, S. (2004) Elevation of platelet activation markers and chemokines during peripheral blood stem cell harvest with G-CSF. Stem Cells, 22, 696703.
  • Passweg, J.R. (2006) Natural-killer-cell-based treatment in haematopoietic stem-cell transplantation. Best Practice and Research: Clinical Haematology, 19, 811824.
  • Perez, L.E., Alpdogan, O., Shieh, J.H. et al. (2004) Increased plasma levels of stromal-derived factor-1 (SDF-1/CXCL12) enhance human thrombopoiesis and mobilize human colony-forming cells (CFC) in NOD/SCID mice. Experimental Hematology, 32, 300307.
  • Rhodes, B. & Anderlini, P. (2008) Allogeneic peripheral blood stem cell collection as of 2008. Transfusion and Apheresis Science, 38, 219227.
  • Schattenberg, A.V. & Dolstra, H. (2005) Cellular adoptive immunotherapy after allogeneic stem cell transplantation. Current Opinion in Oncology, 17, 617621.
  • Sierra, J., Storer, B., Hansen, J.A. et al. (1997) Transplantation of marrow cells from unrelated donors for treatment of high risk acute leukemia: the effect of leukemic burden, donor HLA-matching, and marrow cell dose. Blood, 89, 42264235.
  • Sorror, M.L., Maris, M.B., Storer, B., Scandmaier, B.M., Diaconescu, R., Flowers, C., Maloney, D.G. & Storb, R. (2004) Comparing morbidity and mortality of HLA-matched unrelated donor hematopoietic cell transplantation after nonmyeloablative and myeloablative conditioning: influence of pretransplantation comorbidities. Blood, 104, 961968.
  • Stroncek, D.F., Clay, M.E., Petzoldt, M.L., Smith, J., Jaszcz, W., Oldham, F.B. & McCullough, J. (1996) Treatment of normal individuals with granulocyte-colony-stimulating factor. Donor experiences and the effects on peripheral blood CD34+ cell counts and on the collection of peripheral blood stem cells. Transfusion, 36, 601610.
  • Suzuya, H., Watanabe, T., Nakagawa, R. et al. (2005) Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors. Vox Sanguinis, 89, 229235.
  • Tassi, C., Tazzari, P.L., Bonifazi, F. et al. (2005) Short-and long-term haematological surveillance of healthy donors of allogeneic peripheral haematopoietic progenitors mobilized with G-CSF: a single institution prospective study. Bone Marrow Transplantation, 36, 289294.
  • Tatsumi, K., Otani, H., Sato, D., Enoki, C. & Iwasaka, T. (2008) Granulocyte-colony stimulating factor increases donor mesenchymal stem cells in bone marrow and their mobilization into peripheral circulation but does not repair dystrophic heart after bone marrow transplantation. Circulation Journal, 72, 13511358.
  • Tomblyn, M., Gordon, L., Singhal, S., Tallman, M.S., Williams, S., Winter, J.N., Evens, A. & Mehta, J. (2005) Use of total leukocyte and platelet counts to guide stem cell apheresis in healthy allogeneic donors treated with G-CSF. Bone Marrow Transplantation, 36, 663668.
  • Topcuoglu, P., Arat, M., Dalva, K. & Ozcan, M. (2004) Administration of granulocyte-colony-stimulating factor for allogeneic hematopoietic cell collection may induce the tissue factor dependent pathway in healthy donors. Bone Marrow Transplantation, 33, 171176.
  • Vasu, S., Leitman, S.F., Tisdale, J.F. et al. (2008) Donor demographic and laboratory predictors of allogeneic peripheral blood stem cell mobilization in an ethnically diverse population. Blood, 112, 20922100.
  • Wang, T.F., Wen, S.H., Chen, R.L. et al. (2008) Factors associated with peripheral blood stem cell yield in volunteer donors mobilized with granulocyte colony-stimulating factors: the impact of donor characteristics and procedural settings. Biology of Blood and Marrow Transplantation, 14, 13051311.
  • Xing, Z., Ryan, M.A., Daria, D. et al. (2006) Increased hematopoietic stem cell mobilization in aged mice. Blood, 108, 21902197.
  • Zhang, C., Chen, X., Zhang, X., Gao, L., Kong, P.Y., Wang, Q.Y., Peng, X.., Liu, H. (2008) Mobilization of peripheral blood stem cells for autologous transplantation patients with hematologic malignancies: influence of disease, mobilization method, age and sex. Transfusion and Apheresis Science, 39, 2128.